Expression of 17-1A antigen and complement resistance factors CD55 and CD59 on liver metastasis in colorectal cancer
Authors:
- Peter ScheunemannPSPeter Scheunemann
- Manuel LüthMLManuel Lüth
- Stefan InndorfSIStefan Inndorf
- Nikolas H. StoeckleinNSNikolas H. Stoecklein
- A. ErbersdoblerAEA. Erbersdobler
- Alexander RehdersARAlexander Rehders
- Matthias GundlachMGMatthias Gundlach
- Wolfram T. KnoefelWKWolfram T. Knoefel
- Jakob R. IzbickiJIJakob R. Izbicki
- 1 November 2001
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 5 (6) , 673-679
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- Early Lymphatic Tumor Cell Dissemination in Pancreatic CancerPancreas, 1997
- Liver metastases from colorectal cancer: Lessons from past and present clinical studiesBritish Journal of Surgery, 1996
- Monoclonal antibodies in cancer therapyCurrent Opinion in Immunology, 1993
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI: Journal of the National Cancer Institute, 1993
- A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancerCancer, 1991
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Resection of Hepatic Metastases from Colorectal Cancer Biologic PerspectivesAnnals of Surgery, 1989
- Pattern of spread of bloodborne tumourBritish Journal of Surgery, 1986
- PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURSThe Lancet, 1982